Clinical Trial Update: A Phase 2, Double-blind Study to Evaluate Intranasal Trivalent Influenza Virus Vaccine in Healthy Adult [Phase 2]

View source ↗

Summary

Phase 2 double-blind trial evaluating an intranasal trivalent influenza vaccine in healthy adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza Infection

Drugs mentioned

• intranasal trivalent influenza virus vaccine

Snippet

Sponsor: Advagene Biopharma Co. Ltd. | Conditions: Influenza Infection | Phase 2 | Status: COMPLETED